Amid Baby Food Shortage, Abbott Amps up Production
It's converting manufacturing lines to create more Similac
Abbott Laboratories announced Monday it is ramping up production of its infant formula Similac at its Columbus facility amid a nationwide shortage while the company's main production facility in Michigan remains closed over sanitation safety concerns.
The Chicago-based company said in a release it has “prioritized infant formula production” at its Columbus Abbott Nutrition facility, converting other manufacturing lines into manufacturing its Similac “ready-to-feed” baby formula.
An Abbott spokesperson could not immediately be reached Monday for additional details.
Please select this link to read the complete article from Columbus CEO.